Martin Gamez

Martin Gamez is an R&D tax credit specialist with over 25 years of experience in federal and state tax credits and incentives. His background includes Big Four and Top 10 national accounting firms, where he worked across technology, manufacturing, engineering, life sciences, and software. Martin translates complex tax law into practical strategies — from a startup's first R&D claim to multi-year filings for larger enterprises — and supports clients through IRS audit defense. He is a partner at Tax Formulations, based in Los Angeles and serving businesses nationwide.

The Four-Part Test: How the IRS Determines If Your Work Qualifies as R&D

Here’s the question I get asked more than any other: “We improve things all the time — does that count as R&D?” The answer depends entirely on whether your activities pass the IRS four-part test under IRC §41(d). Every dollar of R&D tax credit you claim must trace back to activities that satisfy all four […]

The Four-Part Test: How the IRS Determines If Your Work Qualifies as R&D Read More »

ERC Refund Status 2026: What to Do If Your Claim Is Pending, Denied, or Under Audit

Let me be direct about where things stand: you can no longer file new Employee Retention Credit claims. The filing window officially closed on April 15, 2025, and the OBBBA further restricted eligibility for late-filed 2021 claims. But if your business already filed a claim — whether it’s been paid, denied, or is still sitting

ERC Refund Status 2026: What to Do If Your Claim Is Pending, Denied, or Under Audit Read More »

Cost Segregation Explained: How to Unlock Immediate Tax Savings

Here’s a number that surprises most property owners: 20-40% of a commercial building’s total cost can be reclassified into shorter depreciation schedules — 5, 7, or 15 years instead of the standard 27.5 or 39 (IRS Publication 5653, 2025). That means instead of waiting decades to recover your investment through depreciation, you can front-load a

Cost Segregation Explained: How to Unlock Immediate Tax Savings Read More »

Understanding R&D Tax Credits: Are You Leaving Money on the Table?

Here’s something that still surprises business owners after all these years: 90% of R&D tax credit claims come from small and mid-sized businesses (Boast 2026 Benchmark Report). Not Fortune 500 companies. Not pharmaceutical giants. Businesses like yours. Yet the most common thing I hear from business owners is, “We don’t do R&D.” After 25 years

Understanding R&D Tax Credits: Are You Leaving Money on the Table? Read More »